Join our LinkedIn PATENTSCOPE users Community Group
Feedback
Settings

Settings

Goto Application

222,311 results
Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:C12P

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 22,232
1.WO/2024/096217MODIFIED MICROORGANISM OF GENUS CORYNEBACTERIUM PRODUCING L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING SAME
WO - 10.05.2024
Int.Class C12N 9/00
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
 Appl.No PCT/KR2023/007161 Applicant DAESANG CORPORATION Inventor LEE, Sun Hee
The present invention relates to a modified microorganism of the genus Corynebacterium producing L-glutamic acid and a method for producing L-glutamic acid using same, more specifically to a novel variant of biotin-protein ligase involved in the L-glutamic acid biosynthesis pathway, polynucleotide, and transformant, and a method for producing L-glutamic acid using same. The biotin-protein ligase variant according to the present invention has substitution of one or more amino acids in the amino acid sequence constituting the biotin-protein ligase to result in altered enzyme activity, and thus allows a recombinant microorganism comprising the variant to efficiently produce L-glutamic acid.
2.WO/2024/096218MODIFIED MICROORGANISM OF GENUS CORYNEBACTERIUM PRODUCING L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING SAME
WO - 10.05.2024
Int.Class C12N 9/12
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
10Transferases (2.)
12transferring phosphorus containing groups, e.g. kinases (2.7)
 Appl.No PCT/KR2023/007163 Applicant DAESANG CORPORATION Inventor LEE, Sun Hee
The present invention relates to a modified microorganism of the genus Corynebacterium producing L-glutamic acid and a method for producing L-glutamic acid using same, more specifically to a novel variant of nicotinamide mononucleotide transporter involved in the L-glutamic acid biosynthesis pathway, polynucleotide, and transformant, and a method for producing L-glutamic acid using same. The nicotinamide mononucleotide transporter variant according to the present invention has substitution of one or more amino acids in the amino acid sequence constituting the nicotinamide mononucleotide transporter to result in altered enzyme activity, and thus allows a recombinant microorganism comprising the variant to efficiently produce L-glutamic acid.
3.WO/2024/096038METHOD FOR PRODUCING ACTIVE HGF
WO - 10.05.2024
Int.Class C12N 15/19
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
12Genes encoding animal proteins
19Interferons; Lymphokines; Cytokines
 Appl.No PCT/JP2023/039364 Applicant KRINGLE PHARMA INC. Inventor KAYANO Yoshiyuki
The present invention addresses the problem of providing a method for producing active HGF in an industrially advantageous manner, by expressing HGF α chain and HGF β chain in the same host cell.　The present disclosure provides a method for producing active HGF, the method comprising the following steps 1-4. Step 1: A step for preparing DNA encoding an amino acid sequence including HGF α chain and DNA encoding an amino acid sequence including HGF β chain. Step 2: A step for inserting respective strands of DNA prepared in step 1 into vectors for expressing protein. Step 3: A step for expressing HGF α chain and HGF β chain both in a host cell by co-introducing the vectors obtained in step 2 into the host cell, and culturing the host cell. Step 4: A step for recovering active HGF from a culture supernatant after step 3.
4.WO/2024/092372PROCESS FOR PRODUCTION OF BIOLOGICAL COLORANTS
WO - 10.05.2024
Int.Class C09B 61/00
CCHEMISTRY; METALLURGY
09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES; MORDANTS; LAKES
61Dyes of natural origin prepared from natural sources
 Appl.No PCT/CA2023/051477 Applicant LITE-1 MICROBIAL COLOUR LTD. Inventor GRAHAM, Sarah E
Provided is a process to obtain a target colorant from a microorganism. The process includes fermenting a culture including the microorganism and a nutrition-rich fermentation medium in a first fermentation batch to harvest a fermented broth, treating the fermented broth to produce a target colorant-rich medium and a spent microbial biomass, and utilizing the spent microbial biomass as a partial nutrition-rich medium in a second fermentation batch. Further provided is a fermentation medium for fermenting a microbial seed culture to produce a colorant, the fermentation medium including a spent microbial biomass. The spent microbial biomass is produced in a process including, in a prior fermentation batch, fermenting the seed culture and an initial nutrition-rich fermentation medium to harvest a fermented broth, treating the fermented broth to extract a colorant-rich medium, thereby providing the spent microbial biomass, and sterilizing the spent microbial biomass.
5.WO/2024/094457METHOD FOR PRODUCING GLYCOPROTEIN COMPOSITIONS
WO - 10.05.2024
Int.Class C12P 21/02
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
21Preparation of peptides or proteins
02having a known sequence of two or more amino acids, e.g. glutathione
 Appl.No PCT/EP2023/079453 Applicant F. HOFFMANN-LA ROCHE AG Inventor BOYD, Marina Luise
The present invention relates to a method for recombinantly producing a glycoprotein composition comprising at least one glycoprotein comprising the step of cultivating a recombinant host cell which expresses the glycoprotein in a cultivation medium in a bioreactor having a pH measuring device positioned in the bioreactor and configured to be in physical contact with the cultivation medium, characterized in that (a) the cultivating is performed under sterile conditions, (b) the pH value measured with the pH measuring device differs by 0.05 units or less from the pH value of the cultivation medium, and (c) the relative content of at least one glycosylated variant in the glycoprotein composition has reduced batch-to-batch variability, compared to a method where the pH value measured by the pH measuring device differs by more than 0.05 units, preferably by more than 0.03 units, from the pH value in the cultivation medium, and thereby producing the glycoprotein composition. The present invention further relates to the use of a method for carbon dioxide based pH calibration for improving batch-to-batch variability.
6.WO/2024/095283RECOMBINANT DNA, RECOMBINANT VECTOR FOR PRODUCING DELTA-ACYL LACTONES AND ITS IMPLEMENTATION THEREOF
WO - 10.05.2024
Int.Class C12N 15/52
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
52Genes encoding for enzymes or proenzymes
 Appl.No PCT/IN2023/050997 Applicant NATIONAL INSTITUTE OF IMMUNOLOGY Inventor GOKHALE, Rajesh S.
The present invention discloses a recombinant DNA encoding a protein having an amino acid sequence as set forth in SEQ ID NO: 2, or SEQ ID NO: 4. The present invention further discloses a recombinant vector comprising the recombinant DNA. Furthermore, a recombinant host cell comprising the recombinant vector is also described herein. The present invention further discloses a recombinant protein and a method for producing the said protein. There is also provided herein a method for producing the delta acyl lactone using the recombinant vector and recombinant host cell as described herein.
7.WO/2024/097788GLYCOSYLTRANSFERASE ENGINEERING FOR CHEMOENZYMATIC TOTAL SYNTHESIS OF GANGLIOSIDES
WO - 10.05.2024
Int.Class C07K 14/245
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
195from bacteria
24from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
245Escherichia (G)
 Appl.No PCT/US2023/078398 Applicant THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Inventor GUCCHAIT, Arin
Described herein are Campylobacter jejuni β1–4GalNAcT (CjCgtA) variants comprising a polypeptide having at least 80% identity to the amino acid sequence set forth in SEQ ID NO: 1 or SEQ ID NO: 2. Also described herein are Campylobacter jejuni β1–3-galactosyltransferase (CjCgtB) variants comprising a polypeptide having at least 80% identity to the amino acid sequence set forth in SEQ ID NO: 3. Optionally, in the CjCgtA and CjCgtB variants, the N-terminus of the polypeptide is fused to a maltose binding protein. Further described herein is a method for preparing a glycosylated molecule, comprising: forming a reaction mixture comprising (i) a glycosylation donor comprising a sugar component; (ii) a glycosylation acceptor comprising a sphingosine moiety; and (iii) a glycosyltransferase, wherein the glycosyltransferase is a CjCgtA variant as described herein or a CjCgtB variant as described herein; and maintaining the reaction mixture under conditions suitable for forming a glycosylated molecule.
8.WO/2024/097353RECOMBINANT ALGAE HAVING HIGH BIOMASS AND LIPID PRODUCTIVITY
WO - 10.05.2024
Int.Class C12N 9/12
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
10Transferases (2.)
12transferring phosphorus containing groups, e.g. kinases (2.7)
 Appl.No PCT/US2023/036697 Applicant VIRIDOS, INC. Inventor IMAM, Saheed
The invention provides a recombinant algal organism that has been genetically modified in a gene encoding a protein kinase-like protein. The recombinant organism exhibits higher biomass productivity and higher lipid productivity versus a corresponding control algal organism not having the genetic modification. The recombinant organism is therefore useful in applications requiring biomass and/or lipid productivity, e.g. in the production of biofuels or other lipidic matter. Methods of using the organism and biomass containing or produced by the organism are also provided.
9.WO/2024/095149HYDROLYSED COLLAGEN, PROCESS FOR ITS PREPARATION AND USES THEREOF
WO - 10.05.2024
Int.Class C12P 21/06
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
21Preparation of peptides or proteins
06produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
 Appl.No PCT/IB2023/060956 Applicant URIACH CONSUMER HEALTHCARE, S.L. Inventor BRAVO VÁZQUEZ, Francisca Isabel
The present invention relates to hydrolysed collagen products or collagen hydrolysates, a process for their preparation and their uses as anti-inflammatory and/or analgesic active ingredients for topical applications such as for example as a cream, and for oral applications, such as for example as food or food supplement.
10.WO/2024/093260BACTERIAL TRYPTOPHAN-5-HYDROXYLASE AND USE THEREOF
WO - 10.05.2024
Int.Class C12P 13/22
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
13Preparation of nitrogen-containing organic compounds
04Alpha- or beta-amino acids
22Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
 Appl.No PCT/CN2023/101322 Applicant ZHEJIANG UNIVERSITY Inventor DU, Yiling
Provided are a bacterial tryptophan-5-hydroxylase and use thereof. The bacterial tryptophan-5-hydroxylase comprises the amino acid sequence set forth in SEQ ID NO. 1, SEQ ID NO. 3, or SEQ ID NO. 5, or an amino acid sequence having 50% or higher homology and equivalent functionality to any one of the listed amino acid sequences. A novel bacterial tryptophan-5-hydroxylase family with protoheme as a cofactor capable of catalyzing the production of 5-hydroxytryptophan from tryptophan in vivo or in vitro is identified. The enzyme can be applied to catalyzing the preparation of 5-hydroxytryptophan from tryptophan or applied to the preparation of melatonin. An engineered strain expressing heterologous tryptophan-5-hydroxylase, methyltransferase and decarboxylase genes without tryptophan dioxygenase gene is used as the fermentation strain. Melatonin is specifically produced by means of microorganism fermentation. The method is environment-friendly, cost-efficient, efficient, and thus prospective in industrial production.
# -